Number of SEER-MHOS Respondents (Age 65+) by First Cancer Site, 1998-2007
First Cancer |
Total Number of linked Patients |
Baseline Survey
(Group A) |
Baseline and Follow-up Surveys
(Subset of Group A) |
Baseline Survey before Cancer Diagnosis
(Group B) |
Survey before and
after Cancer
Diagnosis*
(Subset of Group B) |
Baseline Survey after Cancer Diagnosis
(Group C) |
|
|
N |
% |
N |
% |
N |
% |
N |
% |
N |
% |
Prostate |
12,710 |
12,632 |
(99.39) |
5,199 |
(40.90) |
4,510 |
(35.48) |
855 |
(6.73) |
8,974 |
(70.61) |
Breast |
10,283 |
10,218 |
(99.37) |
4,522 |
(43.98) |
3,266 |
(31.76) |
616 |
(5.99) |
7,567 |
(73.59) |
Colorectal |
7,563 |
7,528 |
(99.54) |
3,129 |
(41.37) |
3,170 |
(41.91) |
442 |
(5.84) |
4,799 |
(63.45) |
Lung and bronchus |
5,486 |
5,450 |
(99.34) |
1,842 |
(33.58) |
4,145 |
(75.56) |
273 |
(4.98) |
1,576 |
(28.73) |
Gynecological Cancers |
3,292 |
3,279 |
(99.61) |
1,423 |
(43.23) |
907 |
(27.55) |
123 |
(3.74) |
2,495 |
(75.79) |
Bladder |
3,193 |
3,173 |
(99.37) |
1,265 |
(39.62) |
1,344 |
(42.09) |
200 |
(6.26) |
2,029 |
(63.55) |
Melanomas -- skin |
2,637 |
2,618 |
(99.28) |
1,166 |
(44.22) |
1,079 |
(40.92) |
161 |
(6.11) |
1,694 |
(64.24) |
Head and Neck |
2,276 |
2,262 |
(99.38) |
918 |
(40.33) |
982 |
(43.15) |
127 |
(5.58) |
1,407 |
(61.82) |
Kidney and Renal pelvis |
1,205 |
1,195 |
(99.17) |
473 |
(39.25) |
640 |
(53.11) |
88 |
(7.30) |
643 |
(53.36) |
Non-Hodgkin's lymphomas - nodal |
1,240 |
1,234 |
(99.52) |
484 |
(39.03) |
706 |
(56.94) |
65 |
(5.24) |
593 |
(47.82) |
Stomach |
687 |
685 |
(99.71) |
234 |
(34.06) |
474 |
(69.00) |
32 |
(4.66) |
243 |
(35.37) |
Pancreas |
881 |
873 |
(99.09) |
265 |
(30.08) |
781 |
(88.65) |
27 |
(3.06) |
119 |
(13.51) |
Number of individuals with a baseline survey before their first cancer diagnosis and also a baseline or follow-up survey after their first cancer diagnosis.
Note:
- The denominator for the percentages that appear in columns 3 through 7 is the Total Number of Linked Patients by cancer site (column 2).�The groups in columns 3 through 7 are not mutually exclusive, therefore, the percentages do not sum to 100.
- (Group�B + Group C) > Group A because some patients�participated in more than one MHOS cohort and�completed at least one baseline survey before cancer diagnosis and at least one baseline survey after first cancer diagnosis.
|